Skip to main content

Table 2 Table 3

From: HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 study

Percent survival 1-year 2-year 3-year
HIVANA 53 31 28
Patients at risk 19 11 10
Dialysis Patients with other causes of renal failure 83 66 49
Patients at risk 2707 2180 1722
  1. AUnadjusted cumulative percent survival, censored for receipt of renal transplant HIVAN=ESRD due to HIV/AIDS associated nephropathy AIDS=acquired immunodeficiency syndrome
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us